Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Awards
CRO Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Awards
CRO Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Kite Pharma
Manufacturing
BioNTech to wind down cell therapy manufacturing in Maryland
After a poor performance from its CAR-T candidate in a phase 1 cancer trial, BioNTech is ending cell therapy manufacturing at its first U.S. plant.
Fraiser Kansteiner
Jun 18, 2025 10:23am
Gilead's Kite taps Amgen alum as new global commercial head
Jan 16, 2025 10:14am
Daiichi, Fosun, Yuhan and more—Fierce Pharma Asia
Sep 27, 2024 10:15am
Gilead's Kite exits China cell therapy JV with Fosun Pharma
Sep 19, 2024 4:23pm
Kite will evaluate Cellares' cell therapy manufacturing platform
Jun 27, 2024 8:00am
Cytiva rolls out new CAR-T manufacturing platform
May 30, 2024 9:19am
